Evidence map›Paper›PMID 37985923›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy.

Haoyu Yu, Rongyao Gao, Yuxin Liu, Limin Fu, Jing Zhou, Luoyuan Li

Open access · goldAbstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Redox- and Photo-Responsive FeACS applied materials & interfaces · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Haoyu YuThe Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518033, P. R. China.
Rongyao GaoDepartment of Chemistry, Renmin University of China, Beijing, 100872, P. R. China.
Yuxin LiuDepartment of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476, Potsdam, Germany.
Limin FuDepartment of Chemistry, Renmin University of China, Beijing, 100872, P. R. China.
Jing ZhouDepartment of Chemistry, Capital Normal University, Beijing, 100048, P. R. China.
Luoyuan LiThe Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518033, P. R. China.ORCID 0000-0003-3976-182X
Renmin University of China · CNSun Yat-sen University · CNCapital Normal University · CNMax Planck Institute of Colloids and Interfaces · DE

Funding

China Postdoctoral Science Foundation 2018M640145China Postdoctoral Science Foundation 2019T120106High-level talent introduction program at The Eighth Affiliated Hospital of Sun Yat-sen University GCCRCYJ039National Natural Science Foundation of China 22076218National Natural Science Foundation of China 61905130National Natural Science Foundation of China 92159103Shenzhen Science and Technology Program JCYJ20220530144205012
6 · The paper itself

Abstract

Deregulated inflammations induced by various factors are one of the most common diseases in people's daily life, while severe inflammation can even lead to death. Thus, the efficient treatment of inflammation has always been the hot topic in the research of medicine. In the past decades, as a potential biomaterial, stimuli-responsive hydrogels have been a focus of attention for the inflammation treatment due to their excellent biocompatibility and design flexibility. Recently, thanks to the rapid development of nanotechnology and material science, more and more efforts have been made to develop safer, more personal and more effective hydrogels for the therapy of some frequent but tough inflammations such as sepsis, rheumatoid arthritis, osteoarthritis, periodontitis, and ulcerative colitis. Herein, from recent studies and articles, the conventional and emerging hydrogels in the delivery of anti-inflammatory drugs and the therapy for various inflammations are summarized. And their prospects of clinical translation and future development are also discussed in further detail.

Indexed as

Colitis, UlcerativeHydrogelsBiocompatible MaterialsDrug Delivery SystemsHumansInflammationBiocompatible MaterialsHydrogelsdrug deliveryimmune responsesinflammation targeted therapyinflammatory microenvironmentsstimulus-responsive hydrogels

Identifiers

PMID37985923
PMCPMC10767459
OpenAlexW4388850978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.